One of the most common diseases in the modern world is type 2 diabetes, which until now could not be treated. A promising new study could lead to effective treatment for the disease, he writes Discover. Type 2 diabetes or diabetes, although it is influenced by the genes of the individual, it is mainly caused by an unbalanced diet and obesity, especially in old age.
pancreas it is no longer able to produce enough insulin or the body’s cells no longer react to insulin, leading to very high blood glucose levels.
This condition is also known as insulin resistance, and there are currently no drugs or treatments to help cure patients, just a series of treatments to relieve symptoms.
Experts from the University of California have created a drug that has been given to insulin-resistant mice, noting that it eliminates the harmful condition.
Researchers have associated it with type 2 diabetes LMPTP enzyme, which is found in the liver, and it seems that it interacts with cells in such a way that they become insulin resistant.
So the drug had in order to block the LMPTP enzyme, and to the delight of experts (and probably many people if it works), the mouse tests were successful.
“Our findings suggest that LMPTP is a key promoter of insulin resistance and that inhibitors of this enzyme will be beneficial in treating type 2 diabetes.”, stated the authors of the study.
Also, mice showed no side effects. Their cells respond again to the presence of insulin, which regulates sugar levels.
The next step is clinical trials in people with type 2 diabetes. This is very good news for medicine, given that type 2 diabetes will be the seventh leading cause of death by 2030.
–
